Ono Pharmaceutical Co., Ltd. is a renowned pharmaceutical company based in Japan, primarily engaged in the creation and distribution of medicinal products. The company's core mission is to develop inn... Ono Pharmaceutical Co., Ltd. is a renowned pharmaceutical company based in Japan, primarily engaged in the creation and distribution of medicinal products. The company's core mission is to develop innovative treatments that improve patients' quality of life through cutting-edge pharmaceutical research and development. Ono Pharmaceutical plays a significant role in the healthcare sector by focusing on therapeutic areas such as oncology, immunology, cardiovascular diseases, and neuroscience. Among its significant contributions, the company is known for co-developing the immuno-oncology drug Opdivo, a monoclonal antibody used in cancer treatment. Headquartered in Osaka, Ono Pharmaceutical serves a global market, continually seeking breakthroughs in medicine through collaboration with other leading pharmaceutical entities. Its dedication to R&D and contribution to modern healthcare solidifies its importance in advancing medical therapies and addressing critical global health challenges.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Ono Pharmaceutical is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Ono Pharmaceutical is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Ono Pharmaceutical's data?

Create a free Tracenable account to signal interest in having our team review data for Ono Pharmaceutical.

Legal Center Contact Us